New patent expiration for Eiger Biopharms drug ZOKINVY
Annual Drug Patent Expirations for ZOKINVY Zokinvy is a drug marketed by Eiger Biopharms and is included in one NDA. […]
New patent expiration for Eiger Biopharms drug ZOKINVY Read Post »
Patent Expiration
New patent expiration for Septodont Holding drug ORAVERSE
Annual Drug Patent Expirations for ORAVERSE Oraverse is a drug marketed by Septodont Holding and is included in one NDA.
New patent expiration for Septodont Holding drug ORAVERSE Read Post »
New patent expiration for Tolmar drug ELIGARD KIT
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar and is included in four NDAs.
New patent expiration for Tolmar drug ELIGARD KIT Read Post »
New patent expiration for Tolmar drug FENSOLVI KIT
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA.
New patent expiration for Tolmar drug FENSOLVI KIT Read Post »
New patent expiration for Celgene drug REVLIMID
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It
New patent expiration for Schering drug REBETOL
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included
New patent expiration for Currax drug ONZETRA XSAIL
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA.
New patent expiration for Currax drug ONZETRA XSAIL Read Post »
New patent expiration for King Pharms drug LEVOXYL
Annual Drug Patent Expirations for LEVOXYL Levoxyl is a drug marketed by King Pharms and is included in one NDA.
New patent expiration for King Pharms drug LEVOXYL Read Post »
Drug Patent Expirations for the Week of September 24, 2023
NUZYRA (omadacycline tosylate) Paratek pharms inc Patent: 7,326,696 Expiration: Sep 24, 2023 See More … For more information on how
Drug Patent Expirations for the Week of September 24, 2023 Read Post »
